venBio Partners LLC Q3 2025 Filing

Filed November 14, 2025

Portfolio Value

$176.4B

Holdings

6

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
PHVSPHARVARIS N V
4,639,304$115.8B65.62%
2
ALMSALUMIS INC
4,619,803$18.4B10.45%
3
ALXOALX ONCOLOGY HLDGS INC
9,699,925$17.8B10.06%
4
HRMYHARMONY BIOSCIENCES HLDGS IN
489,194$13.5B7.64%
5
LYELLYELL IMMUNOPHARMA INC
473,479$7.7B4.36%
6
ARTVARTIVA BIOTHERAPEUTICS INC
1,148,975$3.3B1.87%